Author(s):
Kajal Pansare, Ganesh Sonawane, Yogesh Ahire, Vinod Bairagi
Email(s):
kajalgsonawane@gmail.com
DOI:
10.52711/2321-5836.2025.00021 
Address:
Kajal Pansare1*, Ganesh Sonawane2, Yogesh Ahire3, Vinod Bairagi4
1Research Scholar, Department of Pharmacology, KBHSS Trusts, Institute of Pharmacy, Malegaon, Nashik - 423203.
2Assistant Professor, Department of Pharmaceutical Chemistry, Divine College of Pharmacy, Satana, Nashik - 4233201.
3Assistant Professor, Department of Pharmacology, KBHSS Trusts, Institute of Pharmacy, Malegaon, Nashik - 423203.
4Professor, Department of Pharmacology, KBHSS Trusts, Institute of Pharmacy, Malegaon, Nashik - 423203.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
Diabetic nephropathy is a major complication of diabetes and a leading cause of end-stage renal failure throughout much of the world. The synthetic drugs are effective in controlling the blood sugar but with many other complications. To overcome this, the need for natural antioxidants, this may be used as a dietary supplement to prevent diabetic nephropathy. Most drugs found to cause nephrotoxicity which exerts toxic effects by one or more common pathogenic mechanisms. Among them, Streptozotocin is the most frequently used drug to induced diabetic nephropathy in rodents offers relevant models to study the effect of antioxidants. The model has so far been used by many researchers to study the effect of drugs in diabetes. In this review, we compiled several antioxidants that are used in the management of Streptozotocin induced diabetic nephropathy with their parameters evaluated.
Cite this article:
Kajal Pansare, Ganesh Sonawane, Yogesh Ahire, Vinod Bairagi. Antioxidants used in Streptozotocin Induced Diabetic Nephropathy: A Concise Review. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):131-6. doi: 10.52711/2321-5836.2025.00021
Cite(Electronic):
Kajal Pansare, Ganesh Sonawane, Yogesh Ahire, Vinod Bairagi. Antioxidants used in Streptozotocin Induced Diabetic Nephropathy: A Concise Review. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):131-6. doi: 10.52711/2321-5836.2025.00021 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-2-8
REFERENCES:
1. Vishwanath, M. and Razdan, R. Ellagic Acid Ameliorates the Progression of Nephropathy in Streptozotocin Induced Diabetic Rats. Int. Res. J. Pharm. 2017; 8: 55–60.
2. Mestry, S. N., Dhodi, J. B., Kumbhar, S. B. and Juvekar, A. R. Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J. Tradit. Complement. Med. 2017; 7: 273–280.
3. Madhan Kumar, S. J., Malarvani, T. and Sathiyanarayamurthy, S. Nephroprotective effects of Cynodon dactylon aqueous extract in STZ induced diabetic male rats–histological study. Int. J. Pharmacogn. Phytochem. Res. 2016; 8: 1812–1817.
4. Gupta, P. et al. Nephroprotective role of alcoholic extract of Pterocarpus marsupium heartwood against experimentally induced diabetic nephropathy. J. Pharm. Pharmacogn. Res. 2016; 4: 174–186.
5. Almalki, W. H. et al. Zinc Chloride Protects against Streptozotocin-Induced Diabetic Nephropathy in Rats. Pharmacol. and Pharm. 2016; 7: 331–342.
6. Chaudhari, H. S., Bhandari, U. and Khanna, G. Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats. Excli J. 2013; 12: 858–871.
7. Ashrafi, M. et al. Renal Protective Effect of Saffron Aqueous Extract in Streptozotocin Induced Diabetic Rats. Int. J. Med. Res. Heal. Sci. 2017; 6: 151–161.
8. Jamshidi, H. R., Zeinabady, Z., Zamani, E. and Shokrzadeh, M. Attenuation of Diabetic Nephropathy by Carvacrol through Anti-oxidative Effects in Alloxan-Induced Diabetic Rats. 2018; 5: 57–64.
9. C, A. M. Diabetic Kidney Disease: A New Concept for an Old Problem. Open Access J. Urol. Nephrol. 2017; 2.
10. Zhang, G. et al. Diabetic Nephropathy: Causative and Protective Factors. Type Double Blind Peer Rev. Int. Res. J. Publ. Glob. Journals Inc. 2015; 15.
11. Gusain, S. S. and Upadhyaya, K. Anti-Diabetic potential of Girardinia heterophylla in alloxan induced rat model. 2016; 4: 310–316.
12. Hussain, J., Sarhan, H. and Bassal, M. Effect of Syrian Capparis Spinosa Leave Extract on Alloxan-Induced Diabetes in Rats. 2017; 7: 31–43.
13. Kumar, S., Singh, R., Vasudeva, N. and Sharma, S. Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovasc. Diabetol. 2012; 11: 9.
14. Nagarchi, K., Ahmed, S., Sabus, A. and Saheb, S. H. Effect of Streptozotocin on Glucose levels in Albino Wister Rats. 2015; 7.
15. Singh, M. P. and Pathak, K. Animal models for biological screening of anti-diabetic drugs: An overview. 2015; 5: 37–48.
16. Streptozotocin, K. Streptozotocin - A Diabetogenic Agent in Animal Models. 2015.
17. Pandhare, R. Extract of Adenanthera pavonina L. seed reduces development of diabetic nephropathy in streptozotocin-induced diabetic rats. 2012; 2: 233–242.
18. Haroon, H. B. and Murali, A. Antihyperglycemic and neuroprotective effects of Wattakaka volubilis (L. f.) Stapf root against streptozotocin induced diabetes. 2016; 52.
19. Singh, A., Srivastav, R. and Pandey, A. K. Effect of the seeds of Terminalia chebula on blood serum, lipid profile and urine parameters in STZ induced Diabetic rats. 2018; 7: 1–5.
20. Emam, A. et al. Investigate Evaluation of Oxidative Stress and Lipid Profile in STZ-Induced Rats Treated with Antioxidant Vitamin. 2014; 272–279.
21. Islam, M., Rupeshkumar, M. and Reddy, K. B. Streptozotocin is more convenient than Alloxan for the induction of Type 2 diabetes. Int. J. Pharmacol. Res. 2017; 7: 6–11.
22. Lenzen, S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008; 51: 216–226.
23. Tripathi, V. and Verma, J. Review Article Different models used to induce diabetes: a comprehensive review. 2014; 6: 4–7.
24. Feeney, W. P. Alloxan the Chinese or Striped-Back Hamster Animal Models of Type 1 and Type 2 Diabetes Mellitus. 2016.
25. Sharma, R., Dave, V., Sharma, S., Jain, P. and Yadav, S. Experimental Models on Diabetes: A Comprehensive Review. 2013; 4: 1–8.
26. Waleed El Maleky, Amal M. Mahfoz, Afaf O. Osman, Hekma A. Abd El-Latif. Investigation of the impacts of zamzam water on streptozotocin-induced diabetic nephropathy in rats. In-vivo and in-vitro study. Biomedicine and Pharmacotherapy. 2021; 138: 111474.
27. Shikun Yang et., al. Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc. Redox Biology. 2017; 13: 482–497.
28. Manojkumar S Mahajan, Chandrashekhar D Upasani, Aman B Upaganlawar and Vishal S Gulecha, Renoprotective Effect of Co-Enzyme Q10 and N-Acetylcysteine on Streptozotocin-Induced Diabetic Nephropathy in Rats. Int J Diabetes Clin Res. 2020; 7: 123.
29. Guo GuangWang et.,al. Protective Effects of Luteolin onDiabetic Nephropathy in STZ-Induced Diabetic Rats, Evidence-Based Complementary and Alternative Medicine. 2011; 323171:1-7
30. Minghua Zhang et. al. The Attenuation of Moutan Cortex on Oxidative Stress for Renal Injury in AGEs-Induced Mesangial Cell Dysfunction and Streptozotocin-Induced Diabetic Nephropathy Rats, Oxidative Medicine and Cellular Longevity. 2014; 463815: 1-13
31. Munire Kuru Karabas et. al. The Effect of Pioglitazone on Antioxidant Levels and Renal Histopathology in Streptozotocin-Induced Diabetic Rats. ISRN Endocrinology. 2013; 858690: 1-8
32. Ola M. Omran. Effects of Thymoquinone on STZ-induced Diabetic Nephropathy: An Immunohistochemical Study, Informa Healthcare USA
33. Tong et. al. Ethyl Vanillin Protects against Kidney Injury in Diabetic Nephropathy by Inhibiting Oxidative Stress and Apoptosis, Oxidative Medicine and Cellular Longevity, Volume 2019, 2129350, 12
34. Ali S. Alshehri, Kaempferol attenuates diabetic nephropathy in streptozotocin-induced diabetic rats by a hypoglycaemic effect and concomitant activation of the Nrf-2/Ho-1/ antioxidants axis, Archives of Physiology and Biochemistry. 2021: 1-14.
35. Kandemir et. al. Preventive effects of hesperidin on diabetic nephropathy induced by streptozotocin via modulating TGF-b1 and oxidative DNA damage, Toxin Reviews. 2017: 1-7
36. Samy A. Hussein et., al. The Ameliorative Effect of Proanthocyanidins against Streptozotocin Induced Diabetic Nephropathy in Rats. Benha Veterinary Medical Journal. 2018; 34(3): 42-56.
37. Xie et. al. The protective effect of betulinic acid (BA) diabetic nephropathy on streptozotocin (STZ)-induced diabetic rats. Food and Function. 2016
38. Jain et. al. Protective Effect of Diosgenin on Streptozotocin-induced Diabetic Nephropathy in Experimental Rats. International Journal of Pharmaceutical Sciences and Drug Research. 2020; 12(2): 201-207
39. Dubey et. al. Oleanolic acid prevents progression of streptozotocin induced diabetic nephropathy and protects renal microstructures in Sprague Dawley rats. Journal of Pharmacology and Pharmacotherapeutics. 2013; 4(1): 47-52
40. Elbe et. Al. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Human and Experimental Toxicology. 2015; 34(1): 100–113
41. Ahmed et. al. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl- 2 in STZ-induced diabetic rats. Plos-One. 2019: 1-22.
42. Rasheed et. al. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes. Biomedicine and Pharmacotherapy. 2018; 105: 290–298.
43. Xu et. al. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats. Biomedicine and Pharmacotherapy. 2018; 105; 915–921
44. Alhaider et. al Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chemico-Biological Interactions. 2011; 192; 233–242.
45. Wang et. al. Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation. Chemico-Biological Interactions. 2021; 338: 109427.
46. Zabad et. Al. P-Coumaric Acid alleviates experimental diabetic nephropathy through modulation of Toll like receptor -4 in rats. Life Sciences. 2019: 1-27
47. Pei et. al. Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt/GSK-3b signalling pathway. Pharmaceutical Biology. 2022; 60(1): 1732–1738.
48. Mahfoz et. al. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats. Naunyn-Schmiedeberg's Arch Pharmacol. 2016.
49. Ozcan et. al. Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes. Clin Exp Med. 2012; 12: 265–272
50. Sherif et. Al. Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect. J Physiol Biochem. 2014.
51. Jain et. al. The possible antioxidant capabilities of formononetin in guarding against streptozotocin-induced diabetic nephropathy in rats. Future Journal of Pharmaceutical Sciences. 2020: 2-9.
52. Wang et. al. The Protective Effect of Fucoidan in Rats with Streptozotocin-Induced Diabetic Nephropathy. Mar. Drugs. 2014; 12: 3292-3306
53. Wang et. al. Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β signalling pathway in streptozotocin-induced diabetic mice; Human and Experimental Toxicology. 2021; 40(12S): S487–S496
54. Alaofi et. al. Sinapic Acid Ameliorates the Progression of Streptozotocin (STZ)-Induced Diabetic Nephropathy in Rats via NRF2/HO-1 Mediated Pathways. Frontiers in Pharmacology. 2020; 11: 1119,
55. Malik et. al. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-_B-TNF-_ and TGF-_1-MAPK-fibronectin pathways. Am J Physiol Renal Physiol. 2017; 313: F414–F422.